Rallybio Corporation / Fundamentals
Income statement
- Net revenue
€652.94K - Cost of goods sold
€0.00 - Gross profit
€627.20K - SG&A expenses
€14.36M - R&D expenses
€23.50M - EBITDA
-€37.16M - D&A
€99.53K - EBIT
-€37.24M - Interest expenses
€0.00 - EBT
-€35.74M - Tax expenses
-€122.69K - Net income
-€35.74M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€1.36M - Changes in working capital
-€8.17M - Operating cash flow
-€36.03M - Capex
€0.00 - Other investing cash flow
-€4.29M - Net investing cash flow
€29.81M - Total cash dividends paid
€0.00 - Issuance of common stock
-€4.45M - Debt repayment
€0.00 - Other financing cash flow
€6.01K - Net financing cash flow
€14.59K - Foreign exchange effects
€0.00 - Net change in cash
-€6.20M - Cash at end of period
€8.10M - Free cash flow
-€36.03M
Balance sheet
- Cash and cash equivalents
€8.10M - Cash and short-term investments
€39.25M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€3.87M - Total current assets
€43.13M - Property, plant & equipment
€96.10K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€537.11K - Other non-current assets
€0.00 - Total non-current assets
€633.20K - Total assets
€43.76M - Accounts payable
€102.10K - Short-term debt
€49.76K - Other current liabilities
€3.63M - Total current liabilities
€4.32M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€4.32M - Common stock
€3.43K - Retained earnings
-€267.84M - Other equity
€14.59K - Total equity
€39.44M - Total liabilities and shareholders' equity
€43.76M
Company information
- Market capitalization
€11.81M - Employees
25 - Enterprise Value
-€268.72K
Company ratios
- Gross margin
-
96.1% Much better than peer group: 69.3% - EBITDA margin
-
-5,691.3% Much worse than peer group: -452.1% - EBIT margin
-
-5,703.2% Much better than peer group: -7,985.0% - EBT margin
-
-5,473.3% Much better than peer group: -404,034.0% - Net margin
-
-5,473.3% Much worse than peer group: 3,600.1% - ROE
-
-90.6% Much worse than peer group: -12.2% - ROA
-
-81.7% Much worse than peer group: -30.4% - Asset turnover
-
1.5% Much worse than peer group: 56.3% - FCF margin
-
-5,517.9% Much better than peer group: -21,344.5% - FCF yield
-305.2% - Efficiency ratio
5,791.3% - Net sales per employee
-
€26.12K - Net income per employee
-
-€1.43M